This statistic depicts the global revenue of Seretide/Advair around the world from 2012 to 2019 , by region . Seretide/Advair generated a revenue of 1.83 billion British pounds in 2016 in the United States alone . Advair is the brand name marketed in the U.S. and Canada but is known as Seretide in many other countries . This pharmaceutical product is used to treat asthma through a combination of a preventer inhaler and a symptom controller .
